CompletedNot Applicable

mHealth Usage Among Nigeria Women Diagnosed With Breast Cancer Receiving Chemotherapy

Nigeria126 participantsStarted 2022-09-01

Plain-language summary

The research is studying the effect of a mHealth psychoeducational intervention on self-efficacy, coping and psychological distress of Nigerian women diagnosed with breast cancer receiving chemotherapy The study is a two-arm assessor-blinded randomised controlled trial which will be conducted in two University Teaching Hospitals in Nigeria.

Who can participate

Age range18 Years – 70 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. newly diagnosed with breast cancer within the recent three months
✓. currently receiving chemotherapy,
✓. have access to a smartphone and internet,
✓. are able to read and write in English,
✓. are cognitively capable of completing the questionnaires,
✓. consent to join the study.

Exclusion criteria

✕. with a concurrent physical or mental illness (as these might act as a confounder)
✕. cognitively impaired

What they're measuring

Change in self-efficacy

Timeframe: Pre-intervention and immediately after the six weeks intervention

Trial details

NCT IDNCT05489354

SponsorChinese University of Hong Kong

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-03-30

View on ClinicalTrials.gov More Breast Cancer trials